MyAverix Finance
F · Healthcare
Crescent Biopharma, Inc. (C68)
Biotechnology
Crescent Biopharma, Inc. (C68) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $351.54M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for C68
Crescent Biopharma, Inc. (C68) — FAQ
What is Crescent Biopharma, Inc.'s market cap?
Crescent Biopharma, Inc. (C68) has a reported market cap of $351.54M (data as of 2026-03-28).
What is C68's P/E ratio?
The price-to-earnings (P/E) ratio for Crescent Biopharma, Inc. (C68) is 18.00 (data as of 2026-03-28).
Does Crescent Biopharma, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Crescent Biopharma, Inc. (C68). Check the MyAverix Finance app for the latest dividend data.
What sector is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. (C68) is classified in the Healthcare sector (Biotechnology industry).
What exchange is C68 listed on?
C68 is listed on F.
What is Crescent Biopharma, Inc.'s net margin?
Crescent Biopharma, Inc. (C68) reports a net margin of 0.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.